Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Huppert

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Communications Biology|March 24, 2023
Protection against Omicron BA.1/BA.2 severe disease 0-7 months after BNT162b2 boosterOfra Amir, Yair Goldberg, Micha Mandel, et al.
The New England Journal of Medicine|October 27, 2021
Waning Immunity after the BNT162b2 Vaccine in IsraelYair Goldberg, Micha Mandel, Yinon M Bar-On, et al.
The New England Journal of Medicine|September 15, 2021
Protection of BNT162b2 Vaccine Booster against Covid-19 in IsraelYinon M Bar-On, Yair Goldberg, Micha Mandel, et al.
Israel Journal of Health Policy Research|April 21, 2022
The role of statisticians in the response to COVID-19 in Israel: a holistic point of viewItai Dattner, Reuven Gal, Yair Goldberg, et al.
Vaccine|May 3, 2016
Vaccine escape of piliated Streptococcus pneumoniae strainsGili Regev-Yochay, Hanaa Jaber, Ayob Hamdan, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 26, 2021
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1Itzchak Levy, Anat Wieder-Finesod, Vladyslav Litchevsky, et al.
BMC Medicine|June 24, 2016
Modeling the spread of polio in an IPV-vaccinated population: lessons learned from the 2013 silent outbreak in southern IsraelRami Yaari, Ehud Kaliner, Itamar Grotto, et al.
The Lancet. Respiratory Medicine|July 5, 2021
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workersYaniv Lustig, Einav Sapir, Gili Regev-Yochay, et al.
The Lancet Regional Health. Europe|July 12, 2021
Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in IsraelGili Regev-Yochay, Sharon Amit, Moriah Bergwerk, et al.
Lancet (London, England)|February 24, 2022
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regressionDaniel R Feikin, Melissa M Higdon, Laith J Abu-Raddad, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Communications Biology|March 24, 2023
Protection against Omicron BA.1/BA.2 severe disease 0-7 months after BNT162b2 boosterOfra Amir, Yair Goldberg, Micha Mandel, et al.
The New England Journal of Medicine|October 27, 2021
Waning Immunity after the BNT162b2 Vaccine in IsraelYair Goldberg, Micha Mandel, Yinon M Bar-On, et al.
The New England Journal of Medicine|September 15, 2021
Protection of BNT162b2 Vaccine Booster against Covid-19 in IsraelYinon M Bar-On, Yair Goldberg, Micha Mandel, et al.
Israel Journal of Health Policy Research|April 21, 2022
The role of statisticians in the response to COVID-19 in Israel: a holistic point of viewItai Dattner, Reuven Gal, Yair Goldberg, et al.
Vaccine|May 3, 2016
Vaccine escape of piliated Streptococcus pneumoniae strainsGili Regev-Yochay, Hanaa Jaber, Ayob Hamdan, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 26, 2021
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1Itzchak Levy, Anat Wieder-Finesod, Vladyslav Litchevsky, et al.
BMC Medicine|June 24, 2016
Modeling the spread of polio in an IPV-vaccinated population: lessons learned from the 2013 silent outbreak in southern IsraelRami Yaari, Ehud Kaliner, Itamar Grotto, et al.
The Lancet. Respiratory Medicine|July 5, 2021
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workersYaniv Lustig, Einav Sapir, Gili Regev-Yochay, et al.
The Lancet Regional Health. Europe|July 12, 2021
Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in IsraelGili Regev-Yochay, Sharon Amit, Moriah Bergwerk, et al.
Lancet (London, England)|February 24, 2022
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regressionDaniel R Feikin, Melissa M Higdon, Laith J Abu-Raddad, et al.
Pageof 8